Dr. John Campbell is an internet sensation, giving facts & data to help us navigate healthcare in the present day. The interview covers John’s development, work, rise to fame & what he would do to help get healthcare back in shape.
A statement from Dr. Joseph Fraiiman, co-author of the study, Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI −0.4 to 20.6 and −3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated (95 % CI 2.1 to 22.9); risk ratio 1.43 (95 % CI 1.07 to 1.92). The Pfizer trial exhibited a 36 % higher risk of serious adverse events in the vaccine group; risk difference 18.0 per 10,000 vaccinated (95 % CI 1.2 to 34.9); risk ratio 1.36 (95 % CI 1.02 to 1.83). The Moderna trial exhibited a 6 % higher risk of serious adverse events in the vaccine group: risk difference 7.1 per 10,000 (95 % CI –23.2 to 37.4); risk ratio 1.06 (95 % CI 0.84 to 1.33). Combined, there was a 16 % higher risk of serious adverse events in mRNA vaccine recipients: risk difference 13.2 (95 % CI −3.2 to 29.6); risk ratio 1.16 (95 % CI 0.97 to 1.39).
The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes. These analyses will require public release of participant level datasets.
Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin has been found effective for treating the Omicron variant of COVID-19 in a Phase III trial.
Many governments have made nose and mouth covering or face masks compulsory for schoolchildren. The evidence base for this is weak. The question whether nose and mouth covering increases carbon dioxide in inhaled air is crucial. A large-scale survey in Germany of adverse effects in parents and children using data of 25 930 children has shown that 68% of the participating children had problems when wearing nose and mouth coverings.
The normal content of carbon dioxide in the open is about 0.04% by volume (ie, 400 ppm). A level of 0.2% by volume or 2000 ppm is the limit for closed rooms according to the German Federal Environmental Office, and everything beyond this level is unacceptable.
Dr. Peter McCullough has been the world’s most prominent and vocal advocate for early outpatient treatment of SARS-CoV-2 (COVID-19) infection in order to prevent hospitalization and death. On May 19, 2021, I interviewed him about his efforts as a treating physician and researcher. From his unique vantage point, he has observed and documented a profoundly disturbing policy response to the pandemic—a policy response that may prove to be the greatest malpractice and malfeasance in the history of medicine and public health.”
Link to interview audio format released by Julian Charles of The Mind Renewed podcast.
- No evidence that masks reduce viral transmission in real-world settings
- Wearing masks is likely to do harm
- Masks increase compliance with the ongoing public health tyranny
- Masks are dehumanising
- Masks perpetuate the elevated levels of fear
The recently-launched Smile Free campaign – of which I’m a part – is campaigning for the removal of mask mandates in the UK, and believes that, in a democratic society, the evidential bar to justify mandating a behaviour should be set very high. The research in support of masks offering protection against SARS-CoV-2 infection falls a long way short of this threshold, and the negative consequences of wearing them are considerable. The decision whether to wear a face covering should be a personal one, not one imposed by Government diktat. All mask mandates must be lifted on June 21 and this most insidious of all the Covid-19 restrictions must never return.
Johnson & Johnson (J&J) has expanded Phase IIa clinical trial of Covid-19 vaccine candidate to include adolescent subjects aged 12 to 17 years.
Ivor Cummins aka the Fat Emperor – gives James the lowdown on why you can’t trust anything our governments tell us about Covid-19. If you want the facts on Coronavirus – how deadly is it? do lockdowns and masks work? how does it compare with previous pandemics? – you’ve come to the right place
Please support the Delingpod:
Mirror archives are available below if this video is removed from YouTube.
Randomised control trial study showing safety and efficacy of COVID-19 vaccine has clear conflicts of interest.
In the end, there was no statistically significant difference between those who wore masks and those who did not when it came to being infected by Covid-19. 1.8 per cent of those wearing masks caught Covid, compared to 2.1 per cent of the control group. As a result, it seems that any effect masks have on preventing the spread of the disease in the community is small.
…there is a troubling lack of robust evidence on face masks and Covid-19…The only studies which have shown masks to be effective at stopping airborne diseases have been ‘observational’…But observational studies are prone to recall bias: in the heat of a pandemic, not very many people will recall if and when they used masks and at what distance they kept from others.
The recommendation to wear surgical masks to supplement other public health measures did not reduce the SARS-CoV-2 infection rate among wearers by more than 50% in a community with modest infection rates, some degree of social distancing, and uncommon general mask use. The data were compatible with lesser degrees of self-protection.
A curated list of mask facts and medical publications.
COVID-19 is as politically-charged as it is infectious. Early in the COVID-19 pandemic, the WHO, the CDC and NIH’s Dr. Anthony Fauci discouraged wearing masks as not useful for non-health care workers. Now they recommend wearing cloth face coverings in public settings where other social distancing measures are hard to do (e.g., grocery stores and pharmacies). The recommendation was published without a single scientific paper or other information provided to support that cloth masks actually provide any respiratory protection. Let’s look at the data.
- Surgical masks are loose fitting. They are designed to protect the patient from the doctors’ respiratory droplets. There wearer is not protected from others’ airborne particles.
- People do not wear masks properly. Many people have the mask under the nose. The wearer does not have glasses on and the eyes are a portal of entry. If the virus lands on the conjunctiva, tears will wash it into the nasopharynx.
- Most studies cannot separate out hand hygiene.
- The designer masks and scarves offer minimal protection. They give a false sense of security to both the wearer and those around the wearer.
**Not to mention they add a perverse lightheartedness to the situation.
- If you are walking alone, no need for a mask. Avoid other folks; use common sense.
- Remember: children under 2 years should not wear masks because of accidental suffocation and difficulty breathing in some.
- Even if a universal mask mandate were imposed, several studies noted that folks do not use the mask properly and over-report their wearing. Additionally, how would the mandate be enforced??
- The positive studies are models that assume universality and full compliance.
- If wearing a mask makes people go out and get Vitamin D – go for it. In the 1918 flu pandemic people who went outside did better. Early reports are showing people with COVID-19 with low Vitamin D do worse than those with normal levels. Perhaps that is why shut-ins do so poorly.
- Science has already proved that masks don’t work.
- Many large Randomised Control Trials (RCT) and meta-analyses over the past decade show masks offer no reduction in risk from respiratory viruses.
- We understand the mechanism of transmission of respiratory disease and the science is clear that masks can’t work.
- It can’t help others when you’re breathing out and it can’t help you when you’re breathing in.
- The mechanism of transmission is through very small aerosol particles.
- Any opening in the mask will allow enough of the minimal dose to infect you.
- One of the effects shown in studies with healthcare workers is that they had an increase in headaches.
- Many articles in support of masks are not relevant e.g. masks stop droplets but transmission is not via droplets.
- Diseases are seasonal because droplets are carried for a long time when the air is dry like in the winter.
Brief Summary:The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.
|Actual Study Start Date :||August 28, 2020|
|Actual Primary Completion Date :||March 5, 2021|
|Estimated Study Completion Date :||February 14, 2023|
The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection. The study is designed to primarily evaluate the efficacy, safety, and immunogenicity of mRNA-1273 to prevent COVID-19 for up to 2 years after the second dose of mRNA-1273.
|Actual Study Start Date :||July 27, 2020|
|Estimated Primary Completion Date :||October 27, 2022|
|Estimated Study Completion Date :||October 27, 2022|
There were 3 influenza pandemics in the 20th century, and there has been 1 so far in the 21st century. Local, national, and international health authorities regularly update their plans for mitigating the next influenza pandemic in light of the latest available evidence on the effectiveness of various control measures in reducing transmission. Here, we review the evidence base on the effectiveness of nonpharmaceutical personal protective measures and environmental hygiene measures in nonhealthcare settings and discuss their potential inclusion in pandemic plans. Although mechanistic studies support the potential effect of hand hygiene or face masks, evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission of laboratory-confirmed influenza. We similarly found limited evidence on the effectiveness of improved hygiene and environmental cleaning. We identified several major knowledge gaps requiring further research, most fundamentally an improved characterization of the modes of person-to-person transmission.
This is a Phase 1/2/3, randomized, placebo-controlled, observer-blind, dose-finding, vaccine candidate-selection, and efficacy study in healthy individuals.
|Actual Study Start Date :||April 29, 2020|
|Estimated Primary Completion Date :||October 29, 2021|
|Estimated Study Completion Date :||April 6, 2023|
Results: Distance was not modified by the mask (P=0.99). Dyspnea variation was significantly higher with surgical mask (+5.6 vs. +4.6; P<0.001) and the difference was clinically relevant. No difference was found for the variation of other parameters.
Conclusion: Wearing a surgical mask modifies significantly and clinically dyspnea without influencing walked distance.
Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza.